Header Logo

Connection

RUIWEN ZHANG to Drug Screening Assays, Antitumor

Back to Details
This is a "connection" page, showing publications RUIWEN ZHANG has written about Drug Screening Assays, Antitumor.
RUIWEN ZHANG
Connection Strength
0.153
Drug Screening Assays, Antitumor
  1. Discovery and Characterization of Dual Inhibitors of MDM2 and NFAT1 for Pancreatic Cancer Therapy. Cancer Res. 2018 10 01; 78(19):5656-5667.
    View in: PubMed
    Score: 0.153
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.